SCHEMBL3835162

SCHEMBL3835162

[c]1oc2ccccc2c1-c1ccc2ccccc2n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 12/20 0.50
NPC1 O15118 11/20 0.50
ALDH1A1 P00352 8/20 0.50
MAPT P10636 5/20 0.50
HSD17B10 Q99714 4/20 0.50
PKM P14618 4/20 0.50
HPGD P15428 4/20 0.50
TP53 P04637 3/20 0.50
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
HCRTR1 O43613 1/20 0.50
KDM4E B2RXH2 10/20 0.43
SMN1; SMN2 Q16637 7/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
LMNA P02545 2/20 0.43
NFKB1 P19838 2/20 0.43
NFKB2 Q00653 2/20 0.43
RELA Q04206 2/20 0.43
ALOX15 P16050 2/20 0.41
TSHR P16473 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4960655 0.79 ADORA3 (0.43) RAB9ANPC1ALDH1A1MAPTHSD17B10
SCHEMBL7474495 0.72 AR (0.39) RAB9ANPC1ALDH1A1MAPTHSD17B10
SCHEMBL5324075 0.72 NPC1 (0.50) RAB9ANPC1ALDH1A1MAPTHSD17B10
SCHEMBL3144177 0.72 RAB9A (0.46) RAB9ANPC1ALDH1A1MAPTHSD17B10
SCHEMBL646759 0.71 KDM4E (0.45) RAB9ANPC1ALDH1A1MAPTHSD17B10
SCHEMBL7143282 0.71 AR (0.44) RAB9ANPC1ALDH1A1MAPTHSD17B10
SCHEMBL3727634 0.70 NPC1 (0.55) RAB9ANPC1ALDH1A1MAPTHSD17B10
SCHEMBL29374931 0.70 RAB9A (0.64) RAB9ANPC1ALDH1A1MAPTHSD17B10
SCHEMBL170196 0.70 RAB9A (0.64) RAB9ANPC1ALDH1A1MAPTHSD17B10
SCHEMBL6256201 0.69 MAPT (0.44) RAB9ANPC1ALDH1A1MAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9849119-B2 Opioid receptor ligands and methods of using and making same TREVENA, INC. (US) 2017-12-26 US disclosed
EP-1940844-B1 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS IRM LLC (BM) 2009-09-30 EP disclosed
US-6440961-B1 Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them DR. REDDY'S RESEARCH FOUNDATION (IN) 2002-08-27 US disclosed